- First, the Fed has done a better job communicating its intentions this time round (personally I think not).
- Secondly and more worryingly, Hilsenrath writes that the markets could be too complacent.
Closing Stock Market SummaryThe S&P 500 (+0.6%) and Nasdaq Composite (+0.7%) set intraday and closing record highs on Thursday while the Dow Jones Industrial Average (+1.0%) and Russell 2000 (+1.3%) outperformed with gains of at least 1.0%. The bullish price action was driven in part by optimism surrounding government-related news.
Namely, the White House unveiled a $1.2 trillion "Bipartisan Infrastructure Framework" that included $579 billion in new spending, bank stocks rallied ahead of the Fed's stress test results after the close, and the FDA granted Breakthrough Therapy designation for Eli Lilly's (LLY 232.97, +15.87, +7.3%) investigational antibody therapy for Alzheimer's disease.
Nine of the 11 S&P 500 sectors contributed to the record-setting performance, paced by financials (+1.2%), energy (+0.9%), communication services (+0.8%), and industrials (+0.8%). The real estate (-0.5%) and utilities (-0.1%) sectors closed lower.
The consumer discretionary sector (+0.1%) featured continued strength in Tesla (TSLA 679.82, +23.25, +3.5%), which extended its weekly gain to 9%, but the sector was held back by Amazon.com (AMZN 3449.08, -54.74, -1.6%).
Some attributed the weakness in Amazon to the House Judiciary Committee advancing several antitrust bills, a report from CNBC highlighting Amazon's publicity surrounding its recent Prime Day event was more muted than previous years, and news that the Teamsters launched an effort to unionize the company's employees.
Separately, weekly initial jobless claims (411,000) stayed above 400,000 for the second straight week but the market overlooked the report in favor of expectations that the labor market will greatly improve in the fall. On a related note, the bipartisan infrastructure framework invests two-thirds of the resources proposed in President Biden's American Jobs Plan, which could ultimately aid in the recovery effort.
Elsewhere, the 10-yr yield settled unchanged at 1.49%, which remained supportive for the stock market. The 2-yr yield increased three basis points to 0.27%. The U.S. Dollar Index was little changed at 91.78. WTI crude futures increased 0.3%, or $0.22, to $73.31/bbl.
Reviewing Thursday's economic data:
- Initial jobless claims for the week ending June 19 decreased by 7,000 to 411,000 ( consensus 380,000). Continuing claims for the week ending June 12 were 3.390 million, which is the lowest since March 21, 2020.
- The key takeaway from the report is that the initial claims level is still quite high, leaving ample room for improvement in a job market that is expected to strengthen in coming months.
- Durable goods orders increased 2.3% month-over-month in May (consensus +2.8%) and were up 25.7% year-over-year. Orders, excluding transportation, increased 0.3% month-over-months (consensus +0.7%) and were up 17.7% year-over-year.
- The key takeaway from the report was the strength seen in transportation equipment (+7.6%), which was driven by a 2.1% increase in orders for motor vehicles and equipment and a 27.4% increase in orders for nondefense aircraft and parts.
- The third estimate for Q1 GDP was unchanged at 6.4%, as expected, while the third estimate for the GDP Price Deflator was also unchanged at 4.3%, as expected.
- The key takeaway from the report is that it's another affirmation of the reopening strength seen in the U.S. economy, although its dated nature (we're almost done with Q2) leaves it devoid of market-moving impact.
- The Advance report for International Trade in Goods for May showed a deficit of $88.1 billion, versus a revised $85.7 billion (from $90.6 billion) in April. The Advance report for Retail Inventories for May decreased 0.8%, while the Advance report for Wholesale Inventories for May increased 1.1%.
Looking ahead, investors will receive Personal Income and Spending for May, PCE Prices for May, and the final University of Michigan Index of Consumer Sentiment for June on Friday.
- Russell 2000 +18.2% YTD
- S&P 500 +13.6% YTD
- Dow Jones Industrial Average +11.7% YTD
- Nasdaq Composite +11.5% YTD
Gapping down
In reaction to earnings/guidance:
- RAD -6.5%, KBH -4.1%, FUL -2.3%, CNXC -2.1%, DRI -0.5%
Other news:
- PRTG -29.9% (files for $200 mln mixed securities shelf offering)
- DQ -9.7% (US to block some solar goods made in Xinjiang region, according to Bloomberg)
- TALO -6.2% (prices secondary offering of 5 mln shares of common stock; additional terms not disclosed)
- BIIB -6% (Biogen and Eisai receive FDA Breakthrough Therapy designation for lecanemab)
- BNL -4.7% (prices offering of 10 mln shares of common stock at $23.00 per share)
- OSW -2.5% (prices offering of 8,421,053 secondary common shares by selling shareholders at $9.50 per share)
- JKS -1.8% (US to block some solar goods made in Xinjiang region, according to Bloomberg)
- HIW -1.6% (sells property)
- THC -1.5% (MPW to acquire five hospitals from THC for $900 mln)
- BSY -1.1% (prices offering of $500.0 mln of convertible senior notes due 2027)
Analyst comments:
- DLTR -1.3% (downgraded to Neutral from Overweight at Piper Sandler)
- LMNL -1% (downgraded to Neutral from Buy at H.C. Wainwright)
Gapping up
In reaction to earnings/guidance:
- SCS +5.2%, ACN +4.4%, GMS +2.2%
Other news:
- ARAV +23.1% (announces "positive" initial results from the Phase 1b portion of its Phase 1b/2 study in patients dosed with 15mg/kg of AVB-500 in combination with cabozantinib who have clear cell renal cell carcinoma)
- DHX +19% (announces additional $12 mln authorization under share buyback program)
- RCUS +18.6% (Phase 2 ARC-7 study with domvanalimab-based combinations showed encouraging clinical activity)
- KUKE +8.8% (Kuke Music Holding's KUKEY Lessons have been included in China's pre-school music education curriculum and deployed in more than 4,000 kindergartens across China)
- LLY +7.3% (donanemab receives FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease)
- ARAY +6.8% (Family pet's lung cancer is treated with targeted radiotherapy using the Accuray Radixact System with Synchrony Technology; Mac, a Fox Terrier Mix, is doing well following radiotherapy treatment)
- AGTC +5.8% (reports 12-month data from its ongoing phase 1/2 achromatopsia clinical trials showing biologic activity in patients with mutations in the ACHM B3 Gene)
- FSP +5.3% (authorizes the repurchase of up to $50 mln)
- BOCH +4.6% (Bank of Commerce to merge into Columbia Banking System (COLB) in all-stock transaction)
- KPTI +4.5% (expands royalty agreement with HealthCare Royalty Management for up to $100 mln)
- FSLR +4.2% (US to block some solar goods made in Xinjiang region, according to Bloomberg)
- KOR +3.7% (received additional drill hole results from the Mother Lode mineral resource expansion program)
- KZIA +3.3% (granted patents by the respective agencies of the United States and India in respect of the manufacturing process for paxalisib)
- IPI +3.2% (announces increase to potash and Trio pricing)
- ZEAL +2.9% (announced that ZEGALOGUE (dasiglucagon) injection 0.6mg/0.6mL is now commercially available in the U.S. in both an auto-injector and prefilled syringe) LODE +2.2% (to purchase an additional 5% of its 45%-owned technology development partner Quantum Generative Materials in exchange for $50 million)
- VKTX +2% (announces the initiation of a Phase 1b clinical trial of VK0214, a novel small molecule agonist of the thyroid hormone receptor beta, in patients with X-linked adrenoleukodystrophy)
- PACB +1.3% (announces collaboration for whole genome sequencing)
- ALNY +1.3% (announces FDA acceptance of new drug application for investigational vutrisiran for the treatment of the polyneuropathy of hereditary ATTR amyloidosis)
- MPW +1.1% (MPW to acquire five hospitals from THC for $900 mln)
- VRAY +1% (GenesisCare expanded its partnership with ViewRay)
Analyst comments:
- MGA +3% (upgraded to Buy from Neutral at Goldman)
- LEA +2.6% (upgraded to Buy from Neutral at Goldman)
- CS +2.5% (upgraded to Buy from Hold at Berenberg)
- MGM +2.5% (upgraded to Buy from Hold at Deutsche Bank)
- APTV +1.8% (upgraded to Buy from Neutral at Guggenheim)
- STX +1.5% (upgraded to Outperform from Market Perform at Northland Capital)


